Pharmacological chromatin remodeling enhances response to estrogen therapy in ER(+) breast cancer.

Journal: Molecular oncology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Johnson Thomas AL, Karakyriakou B, Muskus PC, et al. (2026). "Pharmacological chromatin remodeling enhances response to estrogen therapy in ER(+) breast cancer.". Molecular oncology. https://doi.org/10.1002/1878-0261.70307